Loading...
Please wait, while we are loading the content...
Similar Documents
Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Sandhu, Shahneen K. Omlin, Aurelius G. Hylands, Lucy Miranda, Susana Barber, Louise J. Riisnaes, Ruth Reid, Alison H. M. Attard, Gerhardt Chen, L-J Kozarewa, Iwanka Gevensleben, Heidrun Campbell, J. Fallon Fenwick, Kate Assiotis, I. Olmos, David Cabral Yap, Timothy A. Fong, Peek Tunariu, Nina Koh, Dennis Molife, L. Rhoda Kaye, Sb Lord, Christopher J. Ashworth, Amanda Bono, Johann S. De |
| Copyright Year | 2013 |
| Abstract | 1. Öberg K, Knigge U, Kwekkeboom D et al. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23(Suppl 7):vii124–30. 2. Raymond E, Dahan L, Raoul JL et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N England J Med 2011; 364: 501–513. 3. Yao JC, Shah MH, Ito T et al. Everolimus for advanced pancreatic neuroendocrine tumors. N England J Med 2011; 364: 514–523. 4. Shah MH, Lombard-Bohas C, Ito T et al. Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): impact of somatostatin analog use on progression-free survival in the RADIANT-3 trial. J Clin Oncol 2011; 29 (Suppl.):4010. 5. Pommier RF, Wolin EM, Panneerselvam A et al. Impact of prior chemotherapy on progression-free survival in patients (pts) with advanced pancreatic neuroendocrine tumors (pNET): results from the RADIANT-3 trial. J Clin Oncol 2011; 29(Suppl.):4103. |
| File Format | PDF HTM / HTML |
| DOI | 10.1093/annonc/mdt074 |
| Alternate Webpage(s) | https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/annonc/24/5/10.1093_annonc_mdt074/1/mdt074.pdf?Expires=1493099070&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q&Signature=QattautnkrqXNxMNPYhWvS5TwfGuK~6eeYBmXY54ahCDglZbpAq~ejU-~Jgqq4pGWGZU77kA1oF4TJV-NwWBeN7mM6g9pvdBv66iBiZtTQXj2xB1ETSuvosTtwnfjikRoSNB3SAR3dpeMWFl~tdovDNkKmVzT2OVE6a9oJVxpCTPlE3VZDbZCUUsx7by9MwUDG2ysUW-QMXBFnGAxtEcynH7-zWJyoY~HavVoPHwXuQYUWD7cr5JnSbJ8NVsDzf3oYeqp8I~B6EG85tcWhV3BSW~QPr0e5bRe-oobAaujHtVWwFOsA5cBPx74VGWfkKosMK1UHXuJMcHcrAvRW50Uw__ |
| Alternate Webpage(s) | https://watermark.silverchair.com/mdt074.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAacwggGjBgkqhkiG9w0BBwagggGUMIIBkAIBADCCAYkGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMamoIhnrzuYNv5i97AgEQgIIBWouy7-wefJXf6_GZjxQuYNvJtx5nmKLT7MFvbpv4hzuet164X4-Sqh11lleCe3XmMHFFxOkuhX1BGlVRYVsKngDPzpxLwGRO3LYeRaqkcMh0ZVVVfs4OBnmT_S1EkydglxNJrvECgXOKAMnHTAfqWASbVL7wyIQpMuhWKmOC0zY21jqk3Jk6ljATAYutx7PsxzXiou7hKtRcph-ZileP7Kyg4elGJ0sh3163FRhaRAKdhtcUrSy9OfFnLreEX58oY04EOFnoWCcq8p4MnsTaGs9sFmn711LoDzpkibEaap49vhmXx4fn18WkXEF7kl73cL70UUvyL4I5B4dvlYaYHNPHDDxxGDf2AGheCCBLGPAPCTzgwQeoIDBH2rbS_bA1Hn4EnpTZ1xeQZORYjR8ZWyeZxzMzBkun3441XnWlFA7YaKxOfmx3ho6Kd4mCbSV9lZbg2MMB_yGUQ3o |
| PubMed reference number | 23524863 |
| Alternate Webpage(s) | https://doi.org/10.1093/annonc%2Fmdt074 |
| Journal | Medline |
| Volume Number | 24 |
| Issue Number | 5 |
| Journal | Annals of oncology : official journal of the European Society for Medical Oncology |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |